Locally Optimised Contouring With AI Technology for Radiotherapy
Recruiting now · Not applicable
Conditions studied: Contouring, Segmentation, Radiation Therapy, Artificial Intelligence, Deep Learning
In brief
LOCATOR is a multicentre phase II randomised clinical trial that is looking at the process of contouring in radiation treatment for breast cancer patients. This study looks at whether contouring aided by artificial intelligence (AI) is comparable in quality to that of contouring done completely manually by a radiation oncologist. We are also looking at whether AI assisted contouring saves radiation oncologists time when compared to fully manual contouring. LOCATOR uses the LOCATOR software which is an in-house software developed locally and trained on local data.
Key facts
- Study ID
- NCT06546592
- Run by
- Royal North Shore Hospital
- People needed
- 444
- Starts
- 2025-02-11
- Expected to finish
- 2030-04-30
- Last updated by the study team
- 2026-01-29
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- 18 years and older who are planned for primary breast malignancy
- ECOG performance 0-2
- Ability to understand and willingness to sign a written informed consent document
- The target volume must be able to be objectively reviewed by current published national or international clinical guidelines
You may not qualify if…
- Patients under 18 years of age
- Patients unable to understand consent documents
Where it is running
- Western Cancer Centre Dubbo — Dubbo, New South Wales, Australia (enrolling)
- Central West Cancer Centre — Orange, New South Wales, Australia (enrolling)
- Department of Radiation Oncology, Royal North Shore Hospital — St Leonards, New South Wales, Australia (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.